All News
Filter News
Found 6,648 articles
-
Axxess Pharma, Inc. Enters $35 Billion Arthritis Market Acquiring Canadian Distribution Rights of Unique Pain Relief Medication FORTEX Rubbing Oil(R)
12/16/2010
-
Mologen AG: A Further Clinical Study has Currently been Started - a New Therapy Approach for the Treatment of Renal Cancer
12/14/2010
-
Amicus Therapeutics, Inc. Awarded $500,000 Grant from The Michael J. Fox Foundation for Development of Next-Generation Pharmacological Chaperone to Treat Parkinson's Disease
12/8/2010
-
CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti
12/7/2010
-
Molecular Insight Pharmaceuticals, Inc. Receives Extension of Waiver Agreement With Bond Holders
12/3/2010
-
Theratechnologies Inc. Plans Early Adoption of International Financial Reporting Standards
12/2/2010
-
Shire plc: FIRAZYR FAST-3 Phase 3 Study Endpoints Statistically Significant Results for Hereditary Angioedema
12/1/2010
-
Allergy Therapeutics plc: Ten Further Marketing Authorization Applications Submitted in Germany
12/1/2010
-
Molecular Insight Pharmaceuticals, Inc. Receives Extension of Waiver Agreement With Bond Holders
11/22/2010
-
In Small Test, Experimental Prostate Drug From Exelixis, Inc. Shows Promise
11/19/2010
-
Naurex Inc.: Preclinical Data at Neuroscience 2010 Show Naurex's Novel Antidepressant GLYX-13 Shares Key Efficacy Mechanisms with Ketamine
11/17/2010
-
Vectura Group plc Release: Positive Outcome for VR040 in Parkinson's Trial
11/16/2010
-
Nektar Therapeutics Announces Two Preclinical Data Presentations at Society for Neuroscience 40th Annual Meeting: Neuroscience 2010
11/15/2010
-
Cardium Therapeutics, Inc. Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
11/15/2010
-
Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
11/15/2010
-
NuPathe Inc. Announces Third Quarter 2010 Financial Results and Recent Operational Highlights
11/12/2010
-
Amgen Foundation Recognizes Outstanding Staff Volunteers and Contributes $55,000 to Their Favorite Local Nonprofits
11/12/2010
-
OncoVista Innovative Therapies, Inc. Sells AdnaGen Subsidiary: Total Sale Price Could Reach $65 Million Over Three Years When Milestones Achieved
11/11/2010
-
Horizon Pharma, Inc. Presents HZT-501 Long-Term Safety Data and LODOTRA Phase 3 Data at the American College of Rheumatology Annual Meeting
11/9/2010
-
BioElectronics Corporation Awarded Oral Surgery Pain Management Federal Grant
11/9/2010